Psychosocial barriers to clinical trial participation as perceived by oncologists and patients
Psychosocial barriers to clinical trial participation as perceived by oncologists and patients
复制标题
肿瘤学家和患者认为参与临床试验的社会心理障碍
DOI：
10.1200/jco.2005.23.16_suppl.6008
复制
发表时间：
2005
期刊：
影响因子：
--
通讯作者：
P. Watts
中科院分区：
文献类型：
--
作者：
N. Meropol;J. Buzaglo;Jennifer Millard;C. Ridgway;N. Damjanov;Suzanne M. Miller;E. Ross;J. Sprandio;P. Watts
6008 Background: Little is known about psychosocial influences on clinical trial (CT) participation by oncologists (oncs) and patients (pts). Methods: A survey was distributed to all 478 medical oncologists in Pennsylvania and a subset of their patients. In addition to demographic characteristics, information on practical and psychosocial barriers to clinical trial participation was evaluated using 5-point Likert scales, and relative ranking. Results: Surveys were completed by 136 oncs (81% men; median age 49 [range 32–71]; 61% non-academic; 14% non-white) and 159 pts (47% men; median age 55 [range 22–85]; 11% non-white; 57% educated beyond high school). 84% of pts heard of CTs; higher education (p<0.0001, Fisher’s Exact) and white race (p<0.0001) were associated with awareness. 98% of oncs and 85% of pts strongly agreed that CTs are important to improving cancer treatment. 79% of oncs strongly agreed that pts benefit from participating, but only 57% of pts felt strongly that they would benefit (p<0.0001,...
